Targeting glycogen synthase kinase-3 in insulin signalling.
about
Glycogen synthase kinase 3: more than a namesakeLithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.GSK3beta: role in therapeutic landscape and development of modulators.The effects of estradiol and catecholestrogens on uterine glycogen metabolism in mink (Neovison vison).Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal.GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesGlycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein.4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain.Effects of streptozotocin-induced type 1 maternal diabetes on PI3K/AKT signaling pathway in the hippocampus of rat neonates.NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3β signalling.Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease.
P2860
Q24315635-3ED190E9-CF53-4D08-8848-CC56C7152FD5Q33607288-10ECB9A6-3BFA-4B29-9E48-EED13CB45212Q33700820-357BC4D1-3958-4149-94C4-24FF459726D1Q33812730-F092F7B4-4FA8-494F-ADAB-3D747B0AA4BDQ34609466-9CE7CAC4-B5C9-4DA5-A59B-8BE88568DF0BQ36959923-00D0F648-C3DF-4A48-BCEF-A37BA3A2A8B1Q37034948-4DBAD11F-CAD1-498F-BBCF-664D3EF26748Q37959957-C8235284-7CB9-4E4F-AABB-001880EE26F4Q38272835-A653B484-CF3C-4AA4-93BE-52220BF09E84Q39289700-67EB2893-0A24-476D-8177-25832D2418D9Q41905676-5B1229EE-911A-4A07-B434-8ABD8ECEE589Q42751805-E3D20241-42EB-44B4-9EC7-7727F850A202Q45241478-800FE923-C969-4BCD-948F-DA6E5F138CD0Q48157530-C0446D38-4708-4E63-9457-EA3938880290Q50554734-D20A665A-C3EB-451B-96F7-29979908E4A6Q51457101-CAC009D1-98C6-4D46-915B-2D000DE73894Q55405257-4A346711-C1C9-47C4-80BB-8F5CB9CA8013
P2860
Targeting glycogen synthase kinase-3 in insulin signalling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Targeting glycogen synthase kinase-3 in insulin signalling.
@ast
Targeting glycogen synthase kinase-3 in insulin signalling.
@en
type
label
Targeting glycogen synthase kinase-3 in insulin signalling.
@ast
Targeting glycogen synthase kinase-3 in insulin signalling.
@en
prefLabel
Targeting glycogen synthase kinase-3 in insulin signalling.
@ast
Targeting glycogen synthase kinase-3 in insulin signalling.
@en
P2860
P1476
Targeting glycogen synthase kinase-3 in insulin signalling.
@en
P2093
Daniella Zheleva
Sheelagh Frame
P2860
P304
P356
10.1517/14728222.10.3.429
P407
P577
2006-06-01T00:00:00Z